rhodioloside has been researched along with Pneumonia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, H; Kang, J; Yin, Y; Zhang, D; Zheng, R | 1 |
| Cai, H; Jin, M; Mo, Y; Song, X; Wang, J; Xue, X; Yang, C; Ye, L; Zhu, G; Zhu, M | 1 |
2 other study(ies) available for rhodioloside and Pneumonia
| Article | Year |
|---|---|
Salidroside ameliorated the pulmonary inflammation induced by cigarette smoke via mitigating M1 macrophage polarization by JNK/c-Jun.
Topics: Animals; Cigarette Smoking; Cytokines; Emphysema; Lung; Macrophages; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Rats; Rats, Wistar | 2023 |
Salidroside suppresses group 2 innate lymphoid cell-mediated allergic airway inflammation by targeting IL-33/ST2 axis.
Topics: Animals; Asthma; Cytokines; Disease Models, Animal; Female; Glucosides; Humans; Hypersensitivity; Immunity, Innate; Immunosuppressive Agents; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Lymphocytes; Mice; Mice, Inbred C57BL; Phenols; Pneumonia; Respiratory System; Rhodiola; Signal Transduction; Th2 Cells | 2020 |